Krystal Biotech (KRYS) Payables (2016 - 2026)
Krystal Biotech's Payables came in at $35.57 million for Q2 2026, up 34.1% from $26.52 million a year earlier and up 14.0% from the prior quarter.
Powered by 
Analysis
Krystal Biotech (KRYS) Payables (2016 - 2026) Analysis & Trends
At the end of FY2025, Krystal Biotech's Payables was $39.75 million, down 32.6% from FY2024.
- Payables carries a five-year compound annual growth rate of 80.0% (FY2020 to FY2025).
- Going back by year, Payables was $58.99 million in FY2024 (+174.2%), $21.51 million in FY2023 (-7.7%), $23.31 million in FY2022 (+43.0%) and $16.3 million in FY2021 (+674.2%).
- The five-year range for quarterly Payables is $16.3 million (Q4 2021) to $58.99 million (Q4 2024).
- Year-over-year, Payables increased in four of the last eight quarters, with growth averaging 30.9%.
- The fastest year-over-year change in Payables over five years came in Q4 2021 (growth of 674.2%), and the weakest in Q1 2023 (a decline of 42.1%).
- Business Quant data shows KRYS's Payables at $31.2 million (Q1 2026), $39.75 million (Q4 2025) and $31.7 million (Q3 2025) in the three quarters before Q2 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 20.92 Bn |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | 33.30 Bn |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | 5.96 Bn |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | 4.26 Bn |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | -22.89 Bn |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 2.87 Bn |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | 674.00 Mn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 7.03 Bn |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | 429.50 Mn |
| 10 | Krystal Biotech | 9.98 Bn | 6.75 Bn | 112.79 Mn | 35.57 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 35.57 Mn |
| Mar 31, 2026 | 31.20 Mn |
| Dec 31, 2025 | 39.75 Mn |
| Sep 30, 2025 | 31.70 Mn |
| Jun 30, 2025 | 26.52 Mn |
| Mar 31, 2025 | 28.05 Mn |
| Dec 31, 2024 | 58.99 Mn |
| Sep 30, 2024 | 53.11 Mn |
| Jun 30, 2024 | 43.33 Mn |
| Mar 31, 2024 | 29.51 Mn |
| Dec 31, 2023 | 21.51 Mn |
| Sep 30, 2023 | 21.74 Mn |
| Jun 30, 2023 | 17.92 Mn |
| Mar 31, 2023 | 29.41 Mn |
| Dec 31, 2022 | 23.31 Mn |
| Sep 30, 2022 | 20.72 Mn |
| Jun 30, 2022 | 23.78 Mn |
| Mar 31, 2022 | 50.82 Mn |
| Dec 31, 2021 | 16.30 Mn |
| Sep 30, 2021 | 30.00 Mn |
API Access
Krystal Biotech Payables API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=payables&ticker=KRYS&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "payables", "ticker": "KRYS", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=payables&ticker=KRYS&period=max&api_key=YOUR_API_KEY");
const data = await res.json();